Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I


Por: Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F and Sellarés, J

Publicada: 1 ene 2026 Ahead of Print: 1 dic 2025
Resumen:
Background: Sarcoidosis is a multi-organ granulomatous disease with a variable course. To predict mortality in routine clinical practice is challenging, thus, it is imperative to identify predictors of mortality in pulmonary sarcoidosis to guide therapy and management effectively. This study aims to evaluate predictors of all-cause mortality at 5 years in patients with pulmonary sarcoidosis from a Spanish cohort. Study design: We developed a retrospective, multicentre analysis from the Spanish pulmonary sarcoidosis cohort (SARCO-I), which included 765 patients diagnosed according to 1999 WASOG criteria. Demographic, clinical, radiological, functional, and laboratory characteristics were analysed. Composite physiological index (CPI) at diagnosis and functional and imaging progression according to the progressive pulmonary fibrosis (PPF) criteria, were also assessed. Univariate and multivariate analyses were performed using Cox proportional hazards models to evaluate predictors of 5-year all-cause mortality. Results: At 5 years from diagnosis, 43 (5.6 %) deaths were reported. Upon multivariate analysis, age at diagnosis and baseline CPI emerged as independent predictors of mortality at 5 years. The age threshold of over 50 years (HR 21.16, CI 95 % 2.75-162) and a CPI >35 (HR 2.84, CI 95 % 1.06-7.6) demonstrated the best discrimination of mortality. The presence of fibrosis at diagnosis, functional deterioration, and radiological progression within the first year did not emerge as predictors of mortality. Conclusion: Age over 50 years and a CPI greater than 35 were identified as independent predictors of 5-year allcause mortality in our Spanish pulmonary sarcoidosis cohort.

Filiaciones:
Ramos, D:
 Inst Nacl Torax, Santiago, Chile

Francesqui, J:
 Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain

 Hosp Clin Barcelona, Barcelona, Spain

Bollo, E:
 Complejo Asistencial Univ Leon, Leon, Spain

Villar, A:
 Hosp Valle De Hebron, Barcelona, Spain

Florez, P:
 Hosp Univ Principe Asturias, Madrid, Spain

Balcells, E:
 Hosp del Mar IMIM, Dept Neumol, Barcelona, Spain

 Univ Pompeu Fabra UPF, Dept Med & Ciencias Vida MELIS, Barcelona, Spain

Castaño, G:
 Hosp Jarrio, Asturias, Spain

Pinillos-Robles, EJ:
 Hosp Univ Fundacio Jimenez Diaz, Madrid, Spain

Godoy-Mayoral, R:
 Complejo Hosp Univ Albacete, Albacete, Spain

Lopez-Muñiz, B:
 Hosp Infanta Leonor, Madrid, Spain

Soler-Sampere, MJ:
 Hosp Gen Univ Elche, Alicante, Spain

Castillo, D:
 Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain

Rafecas-Codern, A:
 Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain

Mariscal-Aguilar, P:
 Hosp Univ La Paz, Madrid, Spain

:
 Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

Gomez-Carrera, L:
 Hosp Univ La Paz, Madrid, Spain

Bonilla, G:
 Hosp Univ La Paz, Madrid, Spain

:
 Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

Hernández-González, F:
 Hosp Clin Barcelona, Barcelona, Spain

Sellarés, J:
 Hosp Clin Barcelona, Barcelona, Spain
ISSN: 09546111





Respiratory Medicine
Editorial
W. B. Saunders Co., Ltd., 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 251 Número:
Páginas: 108591-108591
WOS Id: 001650649700001
ID de PubMed: 41418888

MÉTRICAS